KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Operating Leases (2019 - 2025)

ClearPoint Neuro's Operating Leases history spans 7 years, with the latest figure at $6.2 million for Q3 2025.

  • For Q3 2025, Operating Leases rose 96.17% year-over-year to $6.2 million; the TTM value through Sep 2025 reached $6.2 million, up 96.17%, while the annual FY2024 figure was $3.0 million, 15.61% down from the prior year.
  • Operating Leases for Q3 2025 was $6.2 million at ClearPoint Neuro, down from $6.3 million in the prior quarter.
  • Across five years, Operating Leases topped out at $6.3 million in Q2 2025 and bottomed at $1.4 million in Q1 2023.
  • The 5-year median for Operating Leases is $2.9 million (2025), against an average of $2.9 million.
  • The largest annual shift saw Operating Leases skyrocketed 907.94% in 2021 before it decreased 25.88% in 2022.
  • A 5-year view of Operating Leases shows it stood at $1.9 million in 2021, then fell by 20.99% to $1.5 million in 2022, then soared by 132.9% to $3.6 million in 2023, then fell by 15.61% to $3.0 million in 2024, then skyrocketed by 105.75% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Operating Leases are $6.2 million (Q3 2025), $6.3 million (Q2 2025), and $2.9 million (Q1 2025).